EXEL: Message Board for Exelixis Inc - InvestorVillage

EXEL   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 2500 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
22959 Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study (CABOMAYOR) GN Pacific 3 10/22/2019 10:26:29 PM
22958 Re: WTF???? GN TaiTienMuyBien 0 10/22/2019 10:06:17 PM
22957 Re: WTF???? GN toohearn 1 10/22/2019 6:17:05 PM
22956 Typical October Hangover! GN simbha 0 10/22/2019 5:33:50 PM
22955 Re: WTF???? On second thought.. GN enabeler 1 10/22/2019 12:17:23 PM
22954 Re: WTF???? GN Pharma311 1 10/22/2019 11:37:46 AM
22953 WTF???? GN enabeler Strong Buy 5 10/22/2019 10:23:19 AM
22952 Kidney Cancer: What Is New in the Second-Line Treatment Setting? GN Pacific 4 10/21/2019 3:22:44 PM
22951 Roche's Tecentriq scores a first-in-class double win in new liver cancer patients GN Pacific 3 10/21/2019 1:06:18 PM
22950 Re: Phase II Study With Cabozantinib in Patients With RET Positive NSCLC (CRETA) GN rad.onco 2 10/20/2019 12:28:20 PM
Previous 2500 Messages Top of Message List
Go to Msg #  


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...